So based on that maths - and the increase in sites to 167 - we should see the Stage 2 cohort fully randomised by July 2024 - with the 144 patient/35 week interim readout around March-April 2025. Not bad!
Ann: Investor Presentation, page-144
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.030(5.45%) |
Mkt cap ! $299.6M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 55.5¢ | 51.5¢ | $1.461M | 2.739M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 31651 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 67293 | 5 |
View Market Depth
| Last trade - 13.10pm 24/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |